LLY

1,044.66

-1.42%↓

JNJ

209.1

-2.31%↓

ABBV

222.21

-2.02%↓

UNH

332.13

-2.54%↓

AZN

90.46

-0.63%↓

LLY

1,044.66

-1.42%↓

JNJ

209.1

-2.31%↓

ABBV

222.21

-2.02%↓

UNH

332.13

-2.54%↓

AZN

90.46

-0.63%↓

LLY

1,044.66

-1.42%↓

JNJ

209.1

-2.31%↓

ABBV

222.21

-2.02%↓

UNH

332.13

-2.54%↓

AZN

90.46

-0.63%↓

LLY

1,044.66

-1.42%↓

JNJ

209.1

-2.31%↓

ABBV

222.21

-2.02%↓

UNH

332.13

-2.54%↓

AZN

90.46

-0.63%↓

LLY

1,044.66

-1.42%↓

JNJ

209.1

-2.31%↓

ABBV

222.21

-2.02%↓

UNH

332.13

-2.54%↓

AZN

90.46

-0.63%↓

Kodu・Aktsiate loetelu・VolitionRX Ltd

VolitionRX Ltd

Avatud

0.24

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.23

Max

0.24

Põhinäitajad
By Trading Economics
Sissetulek	936K -5.4M
Müük	221K 627K
Kasumimarginaal	-857.414
Töötajad	75
EBITDA	1.3M -4.2M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+733.33% upside

Turustatistika
By TradingEconomics
Turukapital	-10M 37M
Eelmine avamishind	0.24
Eelmine sulgemishind	0.24

VolitionRX Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. dets 2025, 17:39 UTC

Suurimad hinnamuutused turgudel

Vanda Pharmaceuticals Rises on FDA Biologics License Application

15. dets 2025, 23:44 UTC

Market Talk

Gold Steady Ahead of U.S. Employment Report -- Market Talk

15. dets 2025, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

15. dets 2025, 23:38 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

15. dets 2025, 22:19 UTC

Market Talk

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

15. dets 2025, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

15. dets 2025, 21:42 UTC

Omandamised, ülevõtmised, äriostud

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

15. dets 2025, 21:32 UTC

Omandamised, ülevõtmised, äriostud

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

15. dets 2025, 21:28 UTC

Omandamised, ülevõtmised, äriostud

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

15. dets 2025, 21:26 UTC

Omandamised, ülevõtmised, äriostud

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

15. dets 2025, 21:23 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

15. dets 2025, 21:23 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

15. dets 2025, 21:23 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

15. dets 2025, 21:22 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

15. dets 2025, 21:20 UTC

Omandamised, ülevõtmised, äriostud

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

15. dets 2025, 21:15 UTC

Omandamised, ülevõtmised, äriostud

ServiceNow Completes Acquisition Of Moveworks >NOW

15. dets 2025, 21:00 UTC

Omandamised, ülevõtmised, äriostud

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

15. dets 2025, 20:57 UTC

Omandamised, ülevõtmised, äriostud

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

15. dets 2025, 20:36 UTC

Market Talk

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

15. dets 2025, 20:31 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

15. dets 2025, 20:27 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

15. dets 2025, 20:15 UTC

Market Talk

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

15. dets 2025, 19:22 UTC

Market Talk

Gold and Silver Gain to Start Week -- Market Talk

15. dets 2025, 18:37 UTC

Market Talk

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

15. dets 2025, 18:29 UTC

Market Talk

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

15. dets 2025, 17:58 UTC

Market Talk

Canada Housing Market In Search Of a Bottom -- Market Talk

15. dets 2025, 17:36 UTC

Market Talk

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

15. dets 2025, 17:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. dets 2025, 17:36 UTC

Tulu

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

15. dets 2025, 17:30 UTC

Omandamised, ülevõtmised, äriostud

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

VolitionRX Ltd Prognoos

Hinnasiht

By TipRanks

733.33% tõus

12 kuu keskmine prognoos

Keskmine 2.25 USD 733.33%

Kõrge 3 USD

Madal 1.5 USD

Põhineb 3 Wall Streeti analüütiku instrumendi VolitionRX Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi VolitionRX Ltd aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.